Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study.
Rolf GedeborgHans GarmoCamilla Thellenberg KarlssonGiuseppe FallaraJohan StyrkeIngela Franck LissbrantPär StattinPublished in: Acta oncologica (Stockholm, Sweden) (2022)